.png)
Endocrine Testing Market By Test Types, Technology, End User- Global Industry Analysis And Forecast To 2023
Published On : June 2022 Pages : 180 Category: Medical Devices Report Code : HC06987
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Endocrine Testing Market by Test Types (Estradiol(E2) test, Follicle Stimulating Hormone (FSH) test, Human Chorionic Gonadotropin (hCG) Hormone test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone sulfate(DHEAS) test, Progesterone test, Testosterone test, Thyroid Stimulating Hormone (TSH) test, Prolactin test, Cortisol test, Insulin test), Technology (Tandem Mass Spectrometry, Immunoassay Technology, Monoclonal and Polyclonal Antibody Technology, Sensors Technology, Clinical Chemistry Technology) and End User (Hospitals, Commercial Laboratories, Ambulatory Care Centres) Forecast to 2017 to 2023
Industry Outlook and Trend Analysis
The Endocrine Testing Market was worth USD 6.14 billion in 2017 and is expected to reach approximately USD 12.19 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 7.91% during the forecast period. Endocrine testing alludes to a gathering of tests performed to survey the general capacity of the patient's endocrine framework. The arrival of hormones is connected to an assortment of sicknesses, which makes them a strong marker to uncover the nature and degree of maladies. The rising awareness about the strong association amongst hormones and infections has prompted relentless development of the worldwide endocrine testing market in the on-going past.
Drivers & Restrains
The developing predominance of way of life ailments is likewise anticipated that would add to the interest for endocrine test, consequently adding to the market development. Rising cases for maladies, for example, hypothyroidism and hyperthyroidism is likewise anticipated that would impel the interest for cutting edge endocrine testing technologies. Advancement in advances, for example, acquaintance of simple with work test units encouraged the infiltration of locally established analysis, which is easy to use and financially savvy. Also, the objective of this market is the geriatric population attributable to its expanded defencelessness to ceaseless illnesses and the high danger of creating complexities at a more established age, which makes constant observing basic in these elderly patients.
Regional Outlook and Trend Analysis
North America is expected to witness considerable growth over the forecast period. The presence of very much created essential, auxiliary, tertiary care clinics bolstered the development in the North America region. In addition, a very much created repayment arrange, ideal government financing, and expanding wellbeing awareness encouraged the use of cutting edge procedures for endocrine testing.
Competitive Insights
The leading players in the market are Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Endocrine Testing Market by region is segmented as follows-
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Endocrine Testing Market, By Test Types Estimates and Forecast, 2014-2023($Billion)
o Estradiol(E2) test
o Follicle Stimulating Hormone (FSH) test
o Human Chorionic Gonadotropin (hCG) Hormone test
o Luteinizing Hormone (LH) Test
o Dehydroepiandrosterone sulfate(DHEAS) test
o Progesterone test
o Testosterone test
o Thyroid Stimulating Hormone (TSH) test
o Prolactin test
o Cortisol test
o Insulin test
o Other Test Types
· Endocrine Testing Market, By Technology, Estimates and Forecast, 2014-2023($Billion)
o Tandem Mass Spectrometry
o Immunoassay Technology
o Monoclonal and Polyclonal Antibody Technology
o Sensors Technology
o Clinical Chemistry Technology
o Other Technologies
· Endocrine Testing Market, By End User, Estimates and Forecast, 2014-2023($Billion)
o Hospitals
o Commercial Laboratories
o Ambulatory Care Centers
o Other End Users
· Endocrine Testing Market, By Region, Estimates and Forecast, 2014-2023($Billion)
o North America
§ North America Endocrine Testing Market, By Country
o U.S. Endocrine Testing Market
o Canada Endocrine Testing Market
o Mexico Endocrine Testing Market
o Europe
§ Europe Endocrine Testing Market, By Country
o Germany Endocrine Testing Market
o UK Endocrine Testing Market
o France Endocrine Testing Market
o Russia Endocrine Testing Market
o Italy Endocrine Testing Market
o Rest of Europe Endocrine Testing Market
o Asia-Pacific
§ Asia-Pacific Endocrine Testing Market, By Country
o China Endocrine Testing Market
o Japan Endocrine Testing Market
o South Korea Endocrine Testing Market
o India Endocrine Testing Market
o Southeast Asia Endocrine Testing Market
o Rest of Asia-Pacific Endocrine Testing Market
o South America
§ South America Endocrine Testing Market
o Brazil Endocrine Testing Market
o Argentina Endocrine Testing Market
o Columbia Endocrine Testing Market
o South Africa Endocrine Testing Market
o Rest of South America Endocrine Testing Market
o Middle East and Africa
§ Middle East and Africa Endocrine Testing Market
o Saudi Arabia Endocrine Testing Market
o UAE Endocrine Testing Market
o Egypt Endocrine Testing Market
o Nigeria Endocrine Testing Market
o South Africa Endocrine Testing Market
o Rest of MEA Endocrine Testing Market
Table of Contents
Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Chapter 2. Executive Summary
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
Chapter 4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
Chapter 5. Endocrine Testing Market , By Test Type
5.1. Introduction
5.2. Global Endocrine Testing Revenue and Market Share by Test Type (2017-2027)
5.2.1. Global Endocrine Testing Revenue and Revenue Share by Test Type (2017-2027)
5.3. Estradiol(E2) test
5.3.1. Global Estradiol(E2) test Revenue and Growth Rate (2017-2027)
5.4. Follicle Stimulating Hormone (FSH) test
5.4.1. Global Follicle Stimulating Hormone (FSH) test Revenue and Growth Rate (2017-2027)
5.5. Human Chorionic Gonadotropin (hCG) Hormone test
5.5.1. Global Human Chorionic Gonadotropin (hCG) Hormone test Revenue and Growth Rate (2017-2027)
5.6. Luteinizing Hormone (LH) Test
5.6.1. Global Luteinizing Hormone (LH) Test Revenue and Growth Rate (2017-2027)
5.7. Dehydroepiandrosterone sulfate(DHEAS) test
5.7.1. Global Dehydroepiandrosterone sulfate(DHEAS) test Revenue and Growth Rate (2017-2027)
5.8. Progesterone test
5.8.1. Global Progesterone test Revenue and Growth Rate (2017-2027)
5.9. Testosterone test
5.9.1. Global Testosterone test Revenue and Growth Rate (2017-2027)
5.10. Thyroid Stimulating Hormone (TSH) test
5.10.1. Global Thyroid Stimulating Hormone (TSH) test Revenue and Growth Rate (2017-2027)
5.11. Prolactin test
5.11.1. Global Prolactin test Revenue and Growth Rate (2017-2027)
5.12. Cortisol test
5.12.1. Global Cortisol test Revenue and Growth Rate (2017-2027)
5.13. Insulin test
5.13.1. Global Insulin test Revenue and Growth Rate (2017-2027)
5.14. Other Test Types
5.14.1. Global Other Test Types Revenue and Growth Rate (2017-2027)
Chapter 6. Endocrine Testing Market , By Technology
6.1. Introduction
6.2. Global Endocrine Testing Revenue, Revenue and Market Share by Technology (2017-2027)
6.2.1. Global Endocrine Testing Revenue and Revenue Share by Technology (2017-2027)
6.3. Tandem Mass Spectrometry
6.3.1. Global Tandem Mass Spectrometry Revenue and Growth Rate (2017-2027)
6.4. Immunoassay Technology
6.4.1. Global Immunoassay Technology Revenue and Growth Rate (2017-2027)
6.5. Monoclonal and Polyclonal Antibody Technology
6.5.1. Global Monoclonal and Polyclonal Antibody Technology Revenue and Growth Rate (2017-2027)
6.6. Sensors Technology
6.6.1. Global Sensors Technology Revenue and Growth Rate (2017-2027)
6.7. Clinical Chemistry Technology
6.7.1. Global Clinical Chemistry Technology Revenue and Growth Rate (2017-2027)
6.8. Other Technologies
6.8.1. Global Other Technologies Revenue and Growth Rate (2017-2027)
Chapter 7. Endocrine Testing Market , By End User
7.1. Introduction
7.2. Global Endocrine Testing Revenue, Revenue and Market Share by End User (2017-2027)
7.2.1. Global Endocrine Testing Revenue and Revenue Share by End User (2017-2027)
7.3. Hospitals
7.3.1. Global Hospitals Revenue and Growth Rate (2017-2027)
7.4. Commercial Laboratories
7.4.1. Global Commercial Laboratories Revenue and Growth Rate (2017-2027)
7.5. Ambulatory Care Centres
7.5.1. Global Ambulatory Care Centres Revenue and Growth Rate (2017-2027)
7.6. Other End Users
7.6.1. Global Other End Users Revenue and Growth Rate (2017-2027)
Chapter 8. Endocrine Testing Market , By Region
8.1. Introduction
8.2. Global Endocrine Testing Revenue and Market Share by Regions
8.2.1. Global Endocrine Testing Revenue by Regions (2017-2027)
8.3. North America Endocrine Testing by Countries
8.3.1. North America Endocrine Testing Revenue and Growth Rate (2017-2027)
8.3.2. North America Endocrine Testing Revenue by Countries (2017-2027)
8.3.3. North America Endocrine Testing Revenue (Million USD) by Countries (2017-2027)
8.3.4. U.S.
8.3.4.1. United States Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Canada
8.3.5.1. Canada Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Mexico
8.3.6.1. Mexico Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Endocrine Testing by Countries
8.4.1. Europe Endocrine Testing Revenue and Growth Rate (2017-2027)
8.4.2. Europe Endocrine Testing Revenue by Countries (2017-2027)
8.4.3. Europe Endocrine Testing Revenue (Million USD) by Countries (2017-2027)
8.4.4. Germany
8.4.4.1. Germany Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. France
8.4.6.1. France Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Russia
8.4.7.1. Russia Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Italy
8.4.8.1. Italy Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Rest of Europe
8.4.9.1. Rest of Europe Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Endocrine Testing Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Endocrine Testing Revenue by Countries (2017-2027)
8.5.3. Asia-Pacific Endocrine Testing Revenue (Million USD) by Countries (2017-2027)
8.5.4. China
8.5.4.1. China Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Japan
8.5.5.1. Japan Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5.2.
8.5.6. Korea
8.5.6.1. Korea Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. India
8.5.7.1. India Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Southeast Asia
8.5.8.1. Southeast Asia Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Rest of Asia-Pacific
8.5.9.1. Rest of Asia-Pacific Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Endocrine Testing Revenue and Growth Rate (2017-2027)
8.6.2. South America Endocrine Testing Revenue by Countries (2017-2027)
8.6.3. South America Endocrine Testing Revenue (Million USD) by Countries (2017-2027)
8.6.4. Brazil
8.6.4.1. Brazil Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Argentina
8.6.5.1. Argentina Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Columbia
8.6.6.1. Columbia Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Rest of South America
8.6.7.1. Rest of South America Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Endocrine Testing Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Endocrine Testing Revenue by Countries (2017-2027)
8.7.3. Middle East and Africa Endocrine Testing Revenue (Million USD) by Countries (2017-2027)
8.7.4. Saudi Arabia
8.7.4.1. Saudi Arabia Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. United Arab Emirates
8.7.5.1. United Arab Emirates Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Egypt
8.7.6.1. Egypt Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Nigeria
8.7.7.1. Nigeria Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. South Africa
8.7.8.1. South Africa Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Endocrine Testing Revenue (Millions USD) and Growth Rate (2017-2027)
Chapter 9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Business Overview
9.1.2. Test Type Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue, Revenue and Market Share
9.2. AB Sciex Pte. Ltd.
9.2.1. Business Overview
9.2.2. Test Type Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue, Revenue and Market Share
9.3. Agilent Technologies
9.3.1. Business Overview
9.3.2. Test Type Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue, Revenue and Market Share
9.4. Biomedical Technologies
9.4.1. Business Overview
9.4.2. Test Type Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue, Revenue and Market Share
9.5. bioMerieux SA
9.5.1. Business Overview
9.5.2. Test Type Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue, Revenue and Market Share
9.6. Bio-Rad Laboratories
9.6.1. Business Overview
9.6.2. Test Type Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue, Revenue and Market Share
9.7. DiaSorin S.p.A.
9.7.1. Business Overview
9.7.2. Test Type Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue, Revenue and Market Share
9.8. F. Hoffmann-La Roche Ltd.
9.8.1. Business Overview
9.8.2. Test Type Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue, Revenue and Market Share
9.9. LabCorp
9.9.1. Business Overview
9.9.2. Test Type Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue, Revenue and Market Share
9.10. Ortho Clinical Technology
9.10.1. Business Overview
9.10.2. Test Type Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue, Revenue and Market Share
Chapter 10. Global Endocrine Testing Market Competition, by Manufacturer
10.1. Global Endocrine Testing Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Endocrine Testing Price by Manufacturer (2017-2017)
10.3. Top 5 Endocrine Testing Manufacturer Market Share
10.4. Market Competition Trend
Chapter 11. Endocrine Testing Market Forecast (2027-2023)
11.1. Global Endocrine Testing Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Endocrine Testing Market Forecast by Regions (2027-2023)
11.2.1. North America Endocrine Testing Market Forecast (2027-2023)
11.2.1.1. United States Endocrine Testing Market Forecast (2027-2023)
11.2.1.2. Canada Endocrine Testing Market Forecast (2027-2023)
11.2.1.3. Mexico Endocrine Testing Market Forecast (2027-2023)
11.2.2. Europe Endocrine Testing Market Forecast (2027-2023)
11.2.2.1. Germany Endocrine Testing Market Forecast (2027-2023)
11.2.2.2. United Kingdom Endocrine Testing Market Forecast (2027-2023)
11.2.2.3. France Endocrine Testing Market Forecast (2027-2023)
11.2.2.4. Russia Endocrine Testing Market Forecast (2027-2023)
11.2.2.5. Italy Endocrine Testing Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Endocrine Testing Market Forecast (2027-2023)
11.2.3. Asia-Pacific Endocrine Testing Market Forecast (2027-2023)
11.2.3.1. China Endocrine Testing Market Forecast (2027-2023)
11.2.3.2. Japan Endocrine Testing Market Forecast (2027-2023)
11.2.3.3. Korea Endocrine Testing Market Forecast (2027-2023)
11.2.3.4. India Endocrine Testing Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Endocrine Testing Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Endocrine Testing Market Forecast (2027-2023)
11.2.4. South America Endocrine Testing Market Forecast (2027-2023)
11.2.4.1. Brazil Endocrine Testing Market Forecast (2027-2023)
11.2.4.2. Argentina Endocrine Testing Market Forecast (2027-2023)
11.2.4.3. Columbia Endocrine Testing Market Forecast (2027-2023)
11.2.4.4. Rest of South America Endocrine Testing Market Forecast (2027-2023)
11.2.5. Middle East and Africa Endocrine Testing Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Endocrine Testing Market Forecast (2027-2023)
11.2.5.2. UAE Endocrine Testing Market Forecast (2027-2023)
11.2.5.3. Egypt Endocrine Testing Market Forecast (2027-2023)
11.2.5.4. Nigeria Endocrine Testing Market Forecast (2027-2023)
11.2.5.5. South Africa Endocrine Testing Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Endocrine Testing Market Forecast (2027-2023)
11.3. Endocrine Testing Market Forecast by Test Types (2027-2023)
11.3.1. Global Endocrine Testing Revenue Forecast by Test Types (2027-2023)
11.3.2. Global Endocrine Testing Revenue Market Share Forecast by Test Types (2027-2023)
11.4. Endocrine Testing Market Forecast by Technology (2027-2023)
11.4.1. Global Endocrine Testing Revenue Forecast by Technology (2027-2023)
11.4.2. Global Endocrine Testing Revenue Market Share Forecast by Technology (2027-2023)
11.5. Endocrine Testing Market Forecast by End User (2027-2023)
11.5.1. Global Endocrine Testing Revenue Forecast by End User (2027-2023)
11.5.2. Global Endocrine Testing Revenue Market Share Forecast by End User (2027-2023)
List of Tables
(*You can glance through the list of Tables and Figures when you view the sample copy of Endocrine Testing Market.)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|